MIS Sacroiliac Joint Fusion Market - By Product (Implants, Instruments & Equipment), By Approach (Dorsal, Anterior), By Indication (Trauma, Degenerative Sacroiliitis, Sacroiliac Joint Dysfunction), By End-use & Global Forecast, 2023 – 2032

MIS Sacroiliac Joint Fusion Market Size

MIS Sacroiliac Joint Fusion Market size was valued at around USD 712 million in 2022 and is estimated to register over 12.1% CAGR between 2023 and 2032. Minimally invasive procedures are gaining popularity in the field of spine surgery due to their advantages such as smaller incisions, reduced trauma, faster recovery, and lower complication rates. MIS sacroiliac joint fusion offers patients a less invasive alternative to traditional open surgery, leading to increased adoption.
 

The MIS sacroiliac joint fusion market has witnessed advancements in surgical techniques and technology, including the development of specialized implants and instrumentation. These advancements aim to improve surgical outcomes, reduce complications, and enhance patient satisfaction. Moreover, there is a growing awareness among healthcare professionals about the potential benefits of MIS sacroiliac joint fusion that may propel the market growth positively.
 

Minimally invasive surgical (MIS) fusion of the sacroiliac joint refers to a surgical procedure performed to stabilize and fuse the sacroiliac (SI) joint using minimally invasive techniques. MIS fusion of the sacroiliac joint is typically performed to treat conditions such as sacroiliac joint dysfunction or degeneration that can cause chronic lower back pain and discomfort. The procedure aims to eliminate or reduce pain by fusing the joint together, thereby limiting its motion and restoring stability.
 

However, the complications associated with sacroiliac Joint fusion procedures may restraint the market revenue. As with any surgical procedure, there is a risk of developing an infection at the surgical site. This can result in pain, swelling, redness, and may require additional treatment with antibiotics or further intervention. During the sacroiliac joint fusion procedure, nearby nerves can be damaged, leading to symptoms such as numbness, weakness, or pain in the legs or lower back. These instances are relatively rare but can require additional medical intervention. Hence, the complications associated with sacroiliac Joint fusion procedures may obstruct the business revenue.
 

COVID-19 Impact

The COVID-19 pandemic had negative implications on the MIS sacroiliac joint fusion market. Many elective surgeries including sacroiliac joint fusion were postponed or cancelled during the pandemic. Hospitals and healthcare facilities were focused on treating COVID-19 patients and preserving resources, leading to a backlog of procedures. This backlog had resulted in reduced revenue for medical device manufacturers and providers of MIS sacroiliac joint fusion products. The global supply chain experienced disruptions during the pandemic, affecting the manufacturing and distribution of medical devices. As healthcare resources were redirected to manage the pandemic, hospitals and healthcare providers had to reassess their priorities.
 

Non-emergency procedures comprising sacroiliac joint fusion had been deprioritized, leading to reduced demand and utilization of related products. Additionally, the pandemic prompted a shift towards telehealth and remote care options to reduce in-person contact and preserve healthcare resources. As vaccination rates increased and healthcare systems stabilized, the backlog of delayed procedures was addressed gradually. The MIS sacroiliac joint fusion industry experienced a recovery as healthcare facilities resume elective surgeries, contributing to increased demand for related products.
 

MIS Sacroiliac Joint Fusion Market Trends

Technological advancements played a significant role in the development and improvement of medical procedures including those related to the sacroiliac joint fusion. Advanced navigation system is providing the real-time imaging and guidance during sacroiliac joint fusion surgeries. These systems use preoperative imaging such as CT scans or MRIs, to create a 3D model of the patient's anatomy. Surgeons can then use this model to plan the procedure and guide their tools accurately during surgery, resulting in improved accuracy and better patient outcomes.
 

Robotic-assisted surgery has gained popularity in various fields of medical devices including orthopedics devices. Robotic systems can assist surgeons in performing sacroiliac joint fusion procedures with enhanced precision and control. They offer features such as haptic feedback, improved visualization, and the ability to perform complex movements in tight spaces, making the surgery less invasive and potentially reducing recovery time. Moreover, technological advancements have led to the development of improved implant designs and nanotechnology materials for sacroiliac joint fusion. These implants are specifically designed to provide stability, promote fusion, and allow for optimal load transfer across the joint.
 

MIS Sacroiliac Joint Fusion Market Analysis

Based on product, the MIS sacroiliac joint fusion market is segmented as implants and instruments & equipment. The implants segment dominates the market share in 2022 and is anticipated to crossed USD 458 million. The use of implants in minimally invasive sacroiliac joint fusion is offering several advantages over traditional open surgical techniques. Implants used in MIS SI joint fusion are typically designed to facilitate accurate and controlled placement. This helps ensure proper alignment and fixation of the joint, promoting successful fusion and reducing the risk of complications.
 

The use of implants in MIS SI joint fusion minimizes disruption to the surrounding soft tissues by utilizing minimally invasive techniques and smaller incisions. This can lead to less postoperative pain, reduced muscle damage, and a faster return to normal activities. Thus, the specific advantages of implants used in MIS SI joint fusion will accelerate the product demand. 
 

Based on approach, the MIS sacroiliac joint fusion market is segmented as dorsal and anterior. The dorsal segment acquired dominant market share in 2022 and was worth over USD 413 million. The dorsal (posterior) approach in minimally invasive sacroiliac joint (SIJ) fusion offers several advantages compared to other approaches. The dorsal approach provides direct access to the posterior aspect of the SIJ, that is the target area for fusion. This allows precise placement of implants and facilitates complete joint reconstruction. The dorsal approach avoids manipulation or disruption of vital structures such as major blood vessels, nerves, and the bowel. This reduces the risk of complications associated with injury to these structures. As a result, several advantages associated with the dorsal approach will augment the market growth.
 

Based on indication, the MIS sacroiliac joint fusion market is segmented as trauma, degenerative sacroiliitis, and sacroiliac joint dysfunction. The degenerative sacroiliitis segment accounted major market share in 2022 and reached around USD 392 million. Sacroiliac joint fusion is a surgical procedure widely used to treat degenerative sacroiliitis. Degenerative sacroiliitis can cause chronic pain and discomfort in the lower back, buttocks, and legs. MIS sacroiliac joint fusion is a minimally invasive approach that aims to stabilize the sacroiliac joint and reduce pain.
 

By fusing the sacroiliac joint, the procedure aims to reduce the motion in the joint that can help alleviate pain and improve overall stability. The fusion allows the two bones to heal together over time, forming a solid, immobile connection. As a result, the painful movement and inflammation associated with the degenerated joint are minimized.
 

Based on end-use, the MIS sacroiliac joint fusion market is segmented as hospitals, ambulatory surgical centers, and others. The hospitals segment captured the market in 2022 and is projected to exceed USD 1.13 billion by 2032. Hospital healthcare facilities offer several advantages in the management of sacroiliac joint fusion. Hospitals typically have well-established infrastructure and resources to support complex medical procedures comprising sacroiliac joint fusion. They have state-of-the-art operating rooms, specialized equipment, and a range of healthcare professionals to provide comprehensive care. They may have advanced imaging modalities, computer-assisted navigation systems, and other innovative tools that can enhance the precision and safety of the sacroiliac joint fusion procedure.
 

U.S. held a dominant share in the North America MIS sacroiliac joint fusion market and is set to reach USD 749 million by 2032. North America including the U.S. is one of the major markets for MIS sacroiliac joint fusion. The region has a well-established healthcare infrastructure, a large patient population, and a high prevalence of chronic lower back pain that often includes sacroiliac joint dysfunction. Healthcare professionals in the U.S. may become more confident in recommending the procedure to their patients, as more clinical evidence is accumulated regarding the effectiveness & safety of sacroiliac joint fusion.
 

As the population ages, the incidence of degenerative conditions & chronic pain including sacroiliac joint dysfunction is expected to increase in the coming years. This may drive the demand for sacroiliac joint fusion procedures. 
 

MIS Sacroiliac Joint Fusion Market Share

Some of the major market players operating in the MIS sacroiliac joint fusion market are:

• Camber Spine Technologies
•  LLC
• CoreLink Surgical
•  CornerLoc
•  Globus Medical
•  Life Spine, Inc
•  Medtronic
•  Orthofix Medical Inc
•  PainTEQ and SI-BONE, Inc

 Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.
 

MIS Sacroiliac Joint Fusion Industry News:

• In March 2023, CoreLink announced the FDA Clearance of Siber Ti--3D Printed SI Joint Fusion System. The Siber Ti System offers a comprehensive portfolio of fully porous, nano surfaced, 3D-printed implants. These new implants incorporate CoreLink's patented Mimetic Metal technology designed to emulate natural bone with directional lattice architecture and trabecular pores, while having features at the macro, micro, and nano (MNM) levels. This FDA approval will help the company in surging its revenue growth.
   
• In September 2022, Camber Spine announced the FDA approval for its SPIRA-P Posterior Lumbar Spacer and SPIRA-T Oblique Posterior Lumbar Spacer devices. These products are indicated for use in skeletally mature patients with degenerative disc disease at one or two contiguous levels from L2-S1. As with all products within Camber’s SPIRA technology platform, SPIRA-P and SPIRA-T include strategically placed and optimal sized openings for graft packing. As a result, this product launch assisted the company in augmenting its product portfolio.
   

This MIS sacroiliac joint fusion market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Units) from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product

• Implants
• Instruments & Equipment

By Approach

• Dorsal
• Anterior 

By Indication

• Trauma
• Degenerative Sacroiliitis
• Sacroiliac Joint Dysfunction

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
  • Europe
• Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
• The Netherlands
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
• South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Chile
  • Colombia
  • Peru
• Middle East & Africa
• South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Iran
  • Turkey